Finance

Lists
NVCR:NASDAQ
Novocure Ltd
$11.83
+0.94%
(+0.11) 1D
Nov 13, 4:00:00 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NVCR...
Open
$11.70
High
$11.90
Low
$11.44
Mkt. cap
1.38B
Avg. vol.
1.90M
Volume
1.05M
52-wk high
$21.36
52-wk low
$9.82
EPS
-$1.07
Beta
1.09
Shares outstanding
116.92M
No. of employees
2K
Open
$11.70
High
$11.90
Low
$11.44
Mkt. cap
1.38B
Avg. vol.
1.90M
Volume
1.05M
52-wk high
$21.36
52-wk low
$9.82
EPS
-$1.07
Beta
1.09
Shares outstanding
116.92M
No. of employees
2K
News stories
From web sources and news partners
About Novocure Ltd
CEOAsaf Danziger
Employees1.6K
Founded2000
Headquarters-
SectorHealth Care
IndustryMedical device
Websitenovocure.com
Analyst ratings
Based on 4 analysts giving stock ratings to NVCR in the past 3 months
Strong buy
Buy
3
Hold
1
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for NVCR in the last 3 months.
Highest
Current $11.83
$31.00 (+162.05%)
Average
$23.75 (+100.76%)
Lowest
$15.00 (+26.80%)
Analyst
Recommendation
Action
Price target
Projected
Date
Kevin DeGeeter
Ladenburg Thalmann & Co.
Buy
Maintained
$31.00
+162%
11/10/2026
Unknown Analyst
Wells Fargo
Hold
Reiterated
$15.00
+26.8%
11/10/2026
Vijay Kumar
Evercore ISI
Buy
Maintained
$20.00
+69.1%
10/30/2026
Larry Biegelsen
Wells Fargo
Hold
Reiterated
$15.00
+26.8%
10/30/2026
Jason Bednar
Piper Sandler
Buy
Reiterated
$29.00
+145.1%
10/26/2026
David Nierengarten
Wedbush
Hold
Maintained
$20.00
+69.1%
07/24/2026
Emily Bodnar
H.C. Wainwright
Buy
Reiterated
$52.00
+339.6%
07/24/2026
Jessica Fye
J.P. Morgan
Hold
Maintained
$17.00
+43.7%
07/13/2026
Unknown Analyst
Wedbush
Hold
Maintained
$18.00
+52.2%
06/30/2026
Unknown Analyst
Ladenburg Thalmann & Co.
Buy
Maintained
$27.00
+128.2%
02/27/2026
Last report
Oct 29, 2026
Fiscal period
Q3 2026
-$0.09 / -$0.23
+61.68%beat
Revenue / Est. (USD)
193.40M / 182.23M
+6.13%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
174.35M
174.06M
183.58M
193.40M
Cost of goods sold
40.45M
38.93M
41.11M
44.53M
Cost of revenue
40.45M
38.93M
41.11M
44.53M
Research and development expenses
60.90M
58.34M
51.45M
58.10M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
110.18M
144.21M
101.59M
94.74M
Operating expense
171.09M
202.55M
153.04M
152.84M
Total operating expenses
211.53M
241.48M
194.15M
197.37M
Operating income
-37.18M
-67.42M
-10.56M
-3.97M
Other non operating income
-858.00K
-
-
-
EBT including unusual items
-40.95M
-69.26M
-12.45M
-7.88M
EBT excluding unusual items
-64.64M
-69.26M
-12.45M
-5.68M
Income tax expense
-16.46M
1.88M
3.21M
2.56M
Effective tax rate
40.18%
-2.71%
-25.75%
-32.42%
Other operating expenses
-
-
-
-
Net income
-24.50M
-71.14M
-15.66M
-10.44M
Net profit margin
-14.05%
-40.87%
-8.53%
-5.40%
Earnings per share
-0.22
-0.62
-0.13
-0.09
Interest and investment income
-
3.53M
3.57M
3.84M
Interest expense
-22.27M
-5.37M
-5.46M
-5.54M
Net interest expenses
-22.27M
-1.84M
-1.89M
-1.71M
Depreciation and amortization charges
-
-
-
-
EBITDA
-34.48M
-63.30M
-6.26M
445.00K
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps